Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,025 | -222,611 | -94,594 | 15,566 | -34,382 |
| Depreciation Amortization | 16,375 | 21,506 | 20,413 | 15,937 | 19,251 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -2,126 |
| Accounts receivable | -20,795 | 4,277 | -7,830 | -30,980 | -38,837 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 1,118 |
| Other Working Capital | -11,781 | -17,685 | -4,649 | 14,372 | -36,589 |
| Other Operating Activity | 136,451 | 182,703 | 137,124 | 96,464 | 116,234 |
| Operating Cash Flow | $24,225 | $-31,810 | $50,464 | $111,359 | $24,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 42,153 | 35,359 | 101,840 | -163,365 | -263,762 |
| PPE Investments | -19,231 | -26,804 | -34,097 | -14,180 | -27,408 |
| Net Acquisitions | N/A | -69,496 | -25,720 | N/A | N/A |
| Purchase Sale Intangibles | -46,404 | -24,799 | -8,855 | -9,331 | -4,886 |
| Other Investing Activity | -46,404 | -24,799 | -8,855 | -9,331 | -4,886 |
| Investing Cash Flow | $-23,482 | $-85,740 | $33,168 | $-186,876 | $-296,056 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 306,850 | 0 | 0 | N/A | 278,691 |
| Debt Repayment | -261,936 | 0 | 0 | N/A | -34,069 |
| Common Stock Issued | -6,730 | 4,184 | 17,469 | 51,932 | 69,816 |
| Common Stock Repurchased | -30,000 | 0 | 0 | N/A | N/A |
| Other Financing Activity | 183 | -71 | -592 | 0 | 0 |
| Financing Cash Flow | $8,367 | $4,113 | $16,877 | $51,932 | $314,438 |
| Exchange Rate Effect | 1,256 | -212 | 827 | 153 | 387 |
| Beginning Cash Position | 58,868 | 172,517 | 71,181 | 94,613 | 51,175 |
| End Cash Position | 69,234 | 58,868 | 172,517 | 71,181 | 94,613 |
| Net Cash Flow | $10,366 | $-113,649 | $101,336 | $-23,432 | $43,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,225 | -31,810 | 50,464 | 111,359 | 24,669 |
| Capital Expenditure | -19,231 | -26,804 | -34,097 | -14,180 | -27,408 |
| Free Cash Flow | 4,994 | -58,614 | 16,367 | 97,179 | -2,739 |